PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SYK vs. IHI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between SYK and IHI is 0.75, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.8

Performance

SYK vs. IHI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Stryker Corporation (SYK) and iShares U.S. Medical Devices ETF (IHI). The values are adjusted to include any dividend payments, if applicable.

-5.00%0.00%5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
10.65%
7.25%
SYK
IHI

Key characteristics

Sharpe Ratio

SYK:

1.00

IHI:

0.73

Sortino Ratio

SYK:

1.52

IHI:

1.09

Omega Ratio

SYK:

1.19

IHI:

1.13

Calmar Ratio

SYK:

1.61

IHI:

0.57

Martin Ratio

SYK:

3.97

IHI:

3.11

Ulcer Index

SYK:

4.76%

IHI:

3.30%

Daily Std Dev

SYK:

18.83%

IHI:

14.03%

Max Drawdown

SYK:

-58.63%

IHI:

-49.64%

Current Drawdown

SYK:

-5.78%

IHI:

-8.22%

Returns By Period

In the year-to-date period, SYK achieves a 2.38% return, which is significantly lower than IHI's 3.89% return. Over the past 10 years, SYK has outperformed IHI with an annualized return of 16.24%, while IHI has yielded a comparatively lower 12.85% annualized return.


SYK

YTD

2.38%

1M

-0.87%

6M

10.65%

1Y

18.37%

5Y*

12.96%

10Y*

16.24%

IHI

YTD

3.89%

1M

2.20%

6M

7.25%

1Y

10.81%

5Y*

6.33%

10Y*

12.85%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SYK vs. IHI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SYK
The Risk-Adjusted Performance Rank of SYK is 7878
Overall Rank
The Sharpe Ratio Rank of SYK is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of SYK is 7373
Sortino Ratio Rank
The Omega Ratio Rank of SYK is 7171
Omega Ratio Rank
The Calmar Ratio Rank of SYK is 8888
Calmar Ratio Rank
The Martin Ratio Rank of SYK is 7979
Martin Ratio Rank

IHI
The Risk-Adjusted Performance Rank of IHI is 3535
Overall Rank
The Sharpe Ratio Rank of IHI is 3535
Sharpe Ratio Rank
The Sortino Ratio Rank of IHI is 3535
Sortino Ratio Rank
The Omega Ratio Rank of IHI is 3434
Omega Ratio Rank
The Calmar Ratio Rank of IHI is 3434
Calmar Ratio Rank
The Martin Ratio Rank of IHI is 3939
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SYK vs. IHI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Stryker Corporation (SYK) and iShares U.S. Medical Devices ETF (IHI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SYK, currently valued at 1.00, compared to the broader market-2.000.002.001.000.73
The chart of Sortino ratio for SYK, currently valued at 1.52, compared to the broader market-4.00-2.000.002.004.001.521.09
The chart of Omega ratio for SYK, currently valued at 1.19, compared to the broader market0.501.001.502.001.191.13
The chart of Calmar ratio for SYK, currently valued at 1.61, compared to the broader market0.002.004.006.001.610.57
The chart of Martin ratio for SYK, currently valued at 3.97, compared to the broader market-30.00-20.00-10.000.0010.0020.003.973.11
SYK
IHI

The current SYK Sharpe Ratio is 1.00, which is higher than the IHI Sharpe Ratio of 0.73. The chart below compares the historical Sharpe Ratios of SYK and IHI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00AugustSeptemberOctoberNovemberDecember2025
1.00
0.73
SYK
IHI

Dividends

SYK vs. IHI - Dividend Comparison

SYK's dividend yield for the trailing twelve months is around 0.88%, more than IHI's 0.45% yield.


TTM20242023202220212020201920182017201620152014
SYK
Stryker Corporation
0.88%0.90%1.02%1.16%0.97%0.96%1.02%1.23%1.13%1.31%1.52%1.34%
IHI
iShares U.S. Medical Devices ETF
0.45%0.46%0.53%0.45%0.25%0.25%0.33%0.26%0.37%0.55%1.28%0.65%

Drawdowns

SYK vs. IHI - Drawdown Comparison

The maximum SYK drawdown since its inception was -58.63%, which is greater than IHI's maximum drawdown of -49.64%. Use the drawdown chart below to compare losses from any high point for SYK and IHI. For additional features, visit the drawdowns tool.


-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-5.78%
-8.22%
SYK
IHI

Volatility

SYK vs. IHI - Volatility Comparison

Stryker Corporation (SYK) has a higher volatility of 5.95% compared to iShares U.S. Medical Devices ETF (IHI) at 4.56%. This indicates that SYK's price experiences larger fluctuations and is considered to be riskier than IHI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%9.00%AugustSeptemberOctoberNovemberDecember2025
5.95%
4.56%
SYK
IHI
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab